Canadian-made vaccine trial in Halifax challenged by lack of participants

Published Thursday, May 27, 2021 5:44AM EDT
HALIFAX - Nova Scotia's growing success in getting its population vaccinated against COVID-19 has created a roadblock for a clinical trial of a Canadian-made vaccine.
The Canadian Centre for Vaccinology at Dalhousie University is trying to complete a Phase 1 trial for a COVID-19 vaccine developed by Edmonton-based Entos Pharmaceuticals Inc. but says it's difficult to find volunteers as more people get shots.
The centre's director, Dr. Scott Halperin, says the search is on for about a dozen people aged between 18 and 55 who haven't been vaccinated yet and who haven't been exposed to the virus to complete the initial phase of the trial.

Related Keywords

Canada ,Canadian ,Scott Halperin ,John Lewis ,Entos Pharmaceuticals Inc ,Canadian Centre For Vaccinology At Dalhousie University ,Canadian Centre ,Dalhousie University ,Edmonton Based Entos Pharmaceuticals ,Toronto ,Reaking News ,Crime ,Ive Video ,Ovid 19 Canada ,Covid 19 ,Oronavirus Canada ,Ovid 19 Ontario ,Ntario Covid 19 , ,கனடா ,கனடியன் ,ஸ்காட் ஹால்பெரின் ,ஜான் லெவிஸ் ,கனடியன் மையம் க்கு தடுப்பூசி இல் டால்ஹெளசி பல்கலைக்கழகம் ,கனடியன் மையம் ,டால்ஹெளசி பல்கலைக்கழகம் ,டொராண்டோ ,ரைம் ,விட் ,